Secretome From Mesenchymal Stem Cells Induces Angiogenesis Via Cyr61

被引:114
作者
Estrada, Rosendo [1 ]
Li, Na [1 ]
Sarojini, Harshini [1 ]
An, Jin [1 ]
Lee, Menq-Jer [1 ,2 ]
Wang, Eugenia [1 ,3 ]
机构
[1] Univ Louisville, Sch Med, Gheens Ctr Aging, Louisville, KY 40202 USA
[2] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40202 USA
[3] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40202 USA
关键词
IMMEDIATE-EARLY GENE; GROWTH-FACTOR; STROMAL CELLS; BONE-MARROW; ENDOTHELIAL-CELLS; CCN FAMILY; ADHESION; FIBROBLASTS; PRODUCT; DIFFERENTIATION;
D O I
10.1002/jcp.21701
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It is well known that bone marrow-derived mesenchymal stem cells (MSCs) are involved in wound healing and regeneration responses. In this study, we globally profiled the proteome of MSCs to investigate critical factor(s) that may promote wound healing. Cysteine-rich protein 61 (Cyr61) was found to be abundantly present in MSCs. The presence of Cyr61 was confirmed by immunofluorescence staining and immunoblot analysis. Moreover, we showed that Cyr61 is present in the culture medium (secretome) of MSCs. The secretome of MSCs stimulates angiogenic response in vitro, and neovascularization in vivo. Depletion of Cyr61 completely abrogates the angiogenic-inducing capability of the MSC secretome. Importantly, addition of recombinant Cyr61 polypeptides restores the angiogenic activity of Cyr61-depleted secretome. Collectively, these data demonstrate that Cyr61 polypeptide in MSC secretome contributes to the angiogenesis-promoting activity, a key event needed for regeneration and repair of injured tissues.
引用
收藏
页码:563 / 571
页数:9
相关论文
共 31 条
[1]   Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation [J].
Annabi, B ;
Lee, YT ;
Turcotte, S ;
Naud, E ;
Desrosiers, RR ;
Champagne, M ;
Eliopoulos, N ;
Galipeau, J ;
Béliveau, R .
STEM CELLS, 2003, 21 (03) :337-347
[2]   CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth [J].
Babic, AM ;
Kireeva, ML ;
Kolesnikova, TV ;
Lau, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6355-6360
[3]   Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing [J].
Chamberlain, Giselle ;
Fox, James ;
Ashton, Brian ;
Middleton, Jim .
STEM CELLS, 2007, 25 (11) :2739-2749
[4]   Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin α6β1 and cell surface heparan sulfate proteoglycans [J].
Chen, NY ;
Chen, CC ;
Lau, LF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) :24953-24961
[5]   Functional properties and intracellular signaling of CCN1/Cyr61 [J].
Chen, Ying ;
Du, Xiao-Yan .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (06) :1337-1345
[6]   Simultaneous proteomic profiling of four different growth states of human fibroblasts, using amine-reactive isobaric tagging reagents and tandem mass spectrometry [J].
Cong, YS ;
Fan, E ;
Wang, E .
MECHANISMS OF AGEING AND DEVELOPMENT, 2006, 127 (04) :332-343
[7]   Stimulation of angiogenesis by Cyr61 gene: A new therapeutic candidate [J].
Fataccioli, V ;
Abergel, V ;
Wingertsmann, L ;
Neuville, P ;
Spitz, E ;
Adnot, S ;
Calenda, V ;
Teiger, E .
HUMAN GENE THERAPY, 2002, 13 (12) :1461-1470
[8]   The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells:: potential role in angiogenesis and endothelial regeneration [J].
Grote, Karsten ;
Salguero, Gustavo ;
Ballmaier, Matthias ;
Dangers, Marc ;
Drexler, Helmut ;
Schieffer, Bernhard .
BLOOD, 2007, 110 (03) :877-885
[9]  
HLA T, 1990, J BIOL CHEM, V265, P9308
[10]   Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone [J].
Horwitz, EM ;
Gordon, PL ;
Koo, WKK ;
Marx, JC ;
Neel, MD ;
McNall, RY ;
Muul, L ;
Hofmann, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8932-8937